Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 60, Number 11, June 10, 2003
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caress, J. B.
Right arrow Articles by Peacock, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caress, J. B.
Right arrow Articles by Peacock, J. E., Jr.
Related Collections
Right arrow All Immunology
Right arrow All Neuromuscular Disease
Right arrow Guillain-Barre syndrome
Right arrow Chronic inflammatory demyelinating polyneuropathy
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction

Neurology 2003;60:1822-1824
© 2003 American Academy of Neurology
Brief Communications

The clinical features of 16 cases of stroke associated with administration of IVIg

James B. Caress, MD, Michael S. Cartwright, MD, Peter D. Donofrio, MD and James E. Peacock, Jr., MD

From the Departments of Neurology (Drs. Caress, Cartwright, and Donofrio) and Medicine (Dr. Peacock), Wake Forest University School of Medicine, Winston-Salem, NC.

Address correspondence and reprint requests to Dr. James B. Caress, Department of Neurology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157; e-mail: jcaress{at}wfubmc.edu

This report characterizes the clinical features of 16 cases of stroke associated with IV immunoglobulin infusions. Fourteen of the strokes occurred within 24 hours of an infusion and 50% of the patients were receiving IV immunoglobulin for the first time. Nine patients had multifocal infarctions. All but one of the patients had stroke risk factors.




This article has been cited by other articles:


Home page
 Therapeutic Advances in Neurological DisordersHome page
M. Stangel
Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 115 - 124.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
H. R. Kayyali, A. T. Abdelmoity, M. C. Morriss, and W. D. Graf
Cerebral Venous Thrombosis After Immune Thrombocytopenic Purpura and Anti-D Immune Globulin Therapy
J Child Neurol, March 1, 2008; 23(3): 325 - 330.
[Abstract] [PDF]

Home page
 BloodHome page
J. Chang, P. A. Shi, E. Y. Chiang, and P. S. Frenette
Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion
Blood, January 15, 2008; 111(2): 915 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. A. White and M. C. Leonard
Acute stroke with high-dose intravenous immune globulin
Am. J. Health Syst. Pharm., August 1, 2007; 64(15): 1611 - 1614.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Jarius, P. Eichhorn, M. H. Albert, S. Wagenpfeil, M. Wick, B. H. Belohradsky, R. Hohlfeld, D. E. Jenne, and R. Voltz
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNF{alpha}-dependent and Fc-receptor-independent way
Blood, May 15, 2007; 109(10): 4376 - 4382.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
U Katz and Y Shoenfeld
Review: intravenous immunoglobulin therapy and thromboembolic complications
Lupus, October 1, 2005; 14(10): 802 - 808.
[Abstract] [PDF]

Home page
 Postgrad. Med. J.Home page
K H L Ng, A K L Wu, V C C Cheng, B S F Tang, C Y Chan, C Y Yung, S H Luk, T W Lee, L Chow, and K Y Yuen
Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome
Postgrad. Med. J., June 1, 2005; 81(956): e3 - e3.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
D J. McCabe, S Sumaria, and L A Wilson
Letter to the Editor
Lupus, May 1, 2005; 14(5): 409 - 410.
[PDF]

Home page
 NeurologyHome page
S. Vucic, K. R. Black, P. S. T. Chong, and D. Cros
Multifocal motor neuropathy: Decrease in conduction blocks and reinnervation with long-term IVIg
Neurology, October 12, 2004; 63(7): 1264 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Turhan, P. Jenab, P. Bruhns, J. V. Ravetch, B. S. Coller, and P. S. Frenette
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes
Blood, March 15, 2004; 103(6): 2397 - 2400.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. C. Dalakas and W. M. Clark
Strokes, thromboembolic events, and IVIg: Rare incidents blemish an excellent safety record
Neurology, June 10, 2003; 60(11): 1736 - 1737.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.